These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7052338)

  • 21. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of the alpha-adrenoceptor agonist activity of dobutamine to inotropic selectivity in the anaesthetized cat.
    Kenakin TP; Johnson SF
    Eur J Pharmacol; 1985 May; 111(3):347-54. PubMed ID: 2990956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic changes that accompany the pressor response to propranolol in urethane anesthetized rats subjected to alpha-blockade.
    Abdelrahman A; Pang CC
    Pharmacology; 1990; 40(5):293-300. PubMed ID: 1980368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.
    Tabrizchi R; Pang CC
    Br J Pharmacol; 1990 Oct; 101(2):358-62. PubMed ID: 1979508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alpha 1- and alpha 2-adrenoceptors on basal and adrenaline mediated insulin secretion in rats.
    Langer P
    Endocrinol Exp; 1987 Dec; 21(4):285-90. PubMed ID: 2831021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements.
    Larsson PT; Wallén NH; Egberg N; Hjemdahl P
    Clin Sci (Lond); 1992 Apr; 82(4):369-76. PubMed ID: 1315646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central beta-adrenoceptor involvement in neural control of blood glucose in pigeons.
    Souza WF; Freitas CG; Marino-Neto J; Paschoalini MA
    Physiol Behav; 1996 Sep; 60(3):889-94. PubMed ID: 8873265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamine modulation of magnesium plasma levels in the rat.
    Guideri G
    Arch Int Pharmacodyn Ther; 1992; 320():103-14. PubMed ID: 1363770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris.
    Sundkvist GM; Hjemdahl P; Kahan T; Melcher A
    J Intern Med; 2007 Feb; 261(2):148-58. PubMed ID: 17241180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rise in clotting factor 8 induced in man by adrenaline: effect of alpha- and beta-blockers.
    Ingram GI; Jones RV
    J Physiol; 1966 Nov; 187(2):447-54. PubMed ID: 4382032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of sympatho-adrenal system on insulin sensitivity using the euglycemic clamp technique.
    Kusunoki M; Oshida Y; Iguchi A; Iida T; Suga T; Funado T; Sato Y; Kato K; Sakamoto N
    Diabetes Res Clin Pract; 1992 Aug; 17(2):125-31. PubMed ID: 1425146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A receptor mechanism for the inhibition of insulin release by epinephrine in man.
    Porte D
    J Clin Invest; 1967 Jan; 46(1):86-94. PubMed ID: 6018752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog].
    Mouillé P; Dabiré H; Joly G; Schmitt H
    J Pharmacol; 1983; 14(3):325-32. PubMed ID: 6138461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
    Brockman RP; Halvorson R
    Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shivering and non-shivering therogenesis during summit metabolism in young lambs.
    Alexander G; Williams D
    J Physiol; 1968 Sep; 198(2):251-76. PubMed ID: 5698273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes.
    Shamoon H; Sherwin R
    Diabetologia; 1984 Mar; 26(3):183-9. PubMed ID: 6370767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic interactions between alpha- and beta-adrenoceptor antagonists in conscious or anaesthetized rats.
    Oates HF; Stoker LM
    Clin Exp Pharmacol Physiol; 1980; 7(2):231-6. PubMed ID: 6103770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.